151 related articles for article (PubMed ID: 3121513)
1. Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo.
Zhong GM; Peterson EM; Czarniecki CW; de la Maza LM
Infect Immun; 1988 Jan; 56(1):283-6. PubMed ID: 3121513
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections.
Zhong GM; Peterson EM; Czarniecki CW; Schreiber RD; de la Maza LM
Infect Immun; 1989 Jan; 57(1):152-7. PubMed ID: 2491833
[TBL] [Abstract][Full Text] [Related]
3. Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1.
Zhong GM; de la Maza LM
Infect Immun; 1988 Dec; 56(12):3322-5. PubMed ID: 3141289
[TBL] [Abstract][Full Text] [Related]
4. The influence of vaginally applied imiquimod on the course of Chlamydia trachomatis serovar D infection in a murine model.
Lyons JM; Ito JI; Morré SA
Infect Dis Obstet Gynecol; 2005 Mar; 13(1):1-3. PubMed ID: 16040320
[No Abstract] [Full Text] [Related]
5. Infection of Hysterectomized Mice with Chlamydia muridarum and Chlamydia trachomatis.
Yang C; Whitmire WM; Sturdevant GL; Bock K; Moore I; Caldwell HD
Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28461392
[TBL] [Abstract][Full Text] [Related]
6. Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection.
Qiu H; Yang J; Bai H; Fan Y; Wang S; Han X; Chen L; Yang X
Immunology; 2004 Apr; 111(4):453-61. PubMed ID: 15056383
[TBL] [Abstract][Full Text] [Related]
7. Effect of gamma interferon on resolution of murine chlamydial genital infection.
Rank RG; Ramsey KH; Pack EA; Williams DM
Infect Immun; 1992 Oct; 60(10):4427-9. PubMed ID: 1398955
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.
Perry LL; Su H; Feilzer K; Messer R; Hughes S; Whitmire W; Caldwell HD
J Immunol; 1999 Mar; 162(6):3541-8. PubMed ID: 10092812
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of persistent Chlamydia trachomatis infection in cell culture.
Beatty WL; Morrison RP; Byrne GI
Infect Immun; 1995 Jan; 63(1):199-205. PubMed ID: 7806358
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural analysis of the anti-chlamydial activity of recombinant murine interferon-gamma.
de la Maza LM; Plunkett MJ; Carlson EJ; Peterson EM; Czarniecki CW
Exp Mol Pathol; 1987 Aug; 47(1):13-25. PubMed ID: 3111877
[TBL] [Abstract][Full Text] [Related]
11. Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.
Williams DM; Byrne GI; Grubbs B; Marshal TJ; Schachter J
Infect Immun; 1988 Nov; 56(11):3004-6. PubMed ID: 3139569
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation in human epithelial HeLa cells treated with interferon-γ.
Yamazaki T; Matsuo J; Nakamura S; Oguri S; Yamaguchi H
J Infect Chemother; 2014 Aug; 20(8):460-4. PubMed ID: 24855914
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of apoptosis by gamma interferon in cells and mice infected with Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis).
Perfettini JL; Darville T; Dautry-Varsat A; Rank RG; Ojcius DM
Infect Immun; 2002 May; 70(5):2559-65. PubMed ID: 11953396
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.
Marangoni A; Fiorino E; Gilardi F; Aldini R; Scotti E; Nardini P; Foschi C; Donati M; Montagnani M; Cevenini M; Franco P; Roda A; Crestani M; Cevenini R
Atherosclerosis; 2015 Aug; 241(2):471-9. PubMed ID: 26086356
[TBL] [Abstract][Full Text] [Related]
15. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
[TBL] [Abstract][Full Text] [Related]
16. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease.
Beatty WL; Byrne GI; Morrison RP
Trends Microbiol; 1994 Mar; 2(3):94-8. PubMed ID: 8156277
[TBL] [Abstract][Full Text] [Related]
17. Failure of Chlamydia trachomatis to pass transplacentally to fetuses of TO mice infected during pregnancy.
Tuffrey M; Falder P; Gale J; Taylor-Robinson D
J Med Microbiol; 1988 Jan; 25(1):1-5. PubMed ID: 2961888
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural analysis of the growth cycle of Chlamydia trachomatis in mouse cells treated with recombinant human alpha-interferons.
de la Maza LM; Goebel JM; Czarniecki CW; Peterson EM
Exp Mol Pathol; 1984 Oct; 41(2):227-35. PubMed ID: 6479293
[TBL] [Abstract][Full Text] [Related]
19. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.
Yang X; HayGlass KT; Brunham RC
J Immunol; 1996 Jun; 156(11):4338-44. PubMed ID: 8666805
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes.
Koehler L; Nettelnbreker E; Hudson AP; Ott N; Gérard HC; Branigan PJ; Schumacher HR; Drommer W; Zeidler H
Microb Pathog; 1997 Mar; 22(3):133-42. PubMed ID: 9075216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
